Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 20, 2021BMJOpen Access

What do we know about India’s Covaxin vaccine?

View Full Paper
Ask AI
Bookmark
Share

Authors

KTKamala ThiagarajanMadurai Medical College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kamala Thiagarajan (2021) studied this question.

synapsesocial.com/papers/6a7077778031ec7bb1dc5cf3https://doi.org/10.1136/bmj.n997
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum2021 · 57 citations
  2. 2What do we know about China’s covid-19 vaccines?2021 · 95 citations
  3. 3Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report2020 · 38 citations